Los puntos clave no están disponibles para este artículo en este momento.
The Neo-Bioscore improves our previously validated staging system and allows its application in ERBB2-positive patients. We recommend that treatment response and biologic markers be incorporated into the American Joint Committee on Cancer staging system.
Mittendorf et al. (Thu,) studied this question.